PXMBF
Price
$3.50
Change
+$0.70 (+25.00%)
Updated
May 16 closing price
Capitalization
191.86M
SARTF
Price
$187.87
Change
-$2.13 (-1.12%)
Updated
Aug 22 closing price
Capitalization
14.14B
Interact to see
Advertisement

PXMBF vs SARTF

Header iconPXMBF vs SARTF Comparison
Open Charts PXMBF vs SARTFBanner chart's image
PAXMAN AB
Price$3.50
Change+$0.70 (+25.00%)
Volume$600
Capitalization191.86M
Sartorius AG
Price$187.87
Change-$2.13 (-1.12%)
Volume$1
Capitalization14.14B
PXMBF vs SARTF Comparison Chart in %
Loading...
SARTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PXMBF vs. SARTF commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PXMBF is a Hold and SARTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (PXMBF: $3.50 vs. SARTF: $187.87)
Brand notoriety: PXMBF and SARTF are both not notable
PXMBF represents the Medical/Nursing Services, while SARTF is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: PXMBF: 100% vs. SARTF: 8%
Market capitalization -- PXMBF: $191.86M vs. SARTF: $14.14B
PXMBF [@Medical/Nursing Services] is valued at $191.86M. SARTF’s [@Pharmaceuticals: Other] market capitalization is $14.14B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $231.38B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $167.36B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.66B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PXMBF’s FA Score shows that 0 FA rating(s) are green whileSARTF’s FA Score has 0 green FA rating(s).

  • PXMBF’s FA Score: 0 green, 5 red.
  • SARTF’s FA Score: 0 green, 5 red.
According to our system of comparison, SARTF is a better buy in the long-term than PXMBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SARTF’s TA Score shows that 3 TA indicator(s) are bullish.

  • SARTF’s TA Score: 3 bullish, 4 bearish.

Price Growth

PXMBF (@Medical/Nursing Services) experienced а 0.00% price change this week, while SARTF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -0.02%. For the same industry, the average monthly price growth was +4.22%, and the average quarterly price growth was +24.21%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.24%. For the same industry, the average monthly price growth was +7.04%, and the average quarterly price growth was +16.54%.

Industries' Descriptions

@Medical/Nursing Services (-0.02% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-1.24% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SARTF($14.1B) has a higher market cap than PXMBF($192M). SARTF has higher P/E ratio than PXMBF: SARTF (107.42) vs PXMBF (29.27). SARTF YTD gains are higher at: 2.103 vs. PXMBF (0.000). SARTF has higher annual earnings (EBITDA): 844M vs. PXMBF (57.5M). SARTF has more cash in the bank: 872M vs. PXMBF (153M). PXMBF has less debt than SARTF: PXMBF (9.54M) vs SARTF (4.66B). SARTF has higher revenues than PXMBF: SARTF (3.47B) vs PXMBF (262M).
PXMBFSARTFPXMBF / SARTF
Capitalization192M14.1B1%
EBITDA57.5M844M7%
Gain YTD0.0002.103-
P/E Ratio29.27107.4227%
Revenue262M3.47B8%
Total Cash153M872M18%
Total Debt9.54M4.66B0%
FUNDAMENTALS RATINGS
PXMBF vs SARTF: Fundamental Ratings
PXMBF
SARTF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
76
Overvalued
PROFIT vs RISK RATING
1..100
75100
SMR RATING
1..100
6987
PRICE GROWTH RATING
1..100
7161
P/E GROWTH RATING
1..100
10089
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PXMBF's Valuation (72) in the null industry is in the same range as SARTF (76). This means that PXMBF’s stock grew similarly to SARTF’s over the last 12 months.

PXMBF's Profit vs Risk Rating (75) in the null industry is in the same range as SARTF (100). This means that PXMBF’s stock grew similarly to SARTF’s over the last 12 months.

PXMBF's SMR Rating (69) in the null industry is in the same range as SARTF (87). This means that PXMBF’s stock grew similarly to SARTF’s over the last 12 months.

SARTF's Price Growth Rating (61) in the null industry is in the same range as PXMBF (71). This means that SARTF’s stock grew similarly to PXMBF’s over the last 12 months.

SARTF's P/E Growth Rating (89) in the null industry is in the same range as PXMBF (100). This means that SARTF’s stock grew similarly to PXMBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PXMBFSARTF
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
58%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
64%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
64%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
51%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
9%
Bullish Trend 2 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
9%
Bullish Trend 2 days ago
55%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
61%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
SARTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD1.650.28
+20.44%
Relmada Therapeutics
LAW5.570.07
+1.27%
CS Disco
AGCO111.021.33
+1.21%
AGCO Corp
TILE28.180.30
+1.08%
Interface
CUBWU10.65N/A
N/A
Lionheart Holdings

PXMBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, PXMBF has been loosely correlated with SRDX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if PXMBF jumps, then SRDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PXMBF
1D Price
Change %
PXMBF100%
N/A
SRDX - PXMBF
41%
Loosely correlated
-3.02%
BLOZF - PXMBF
23%
Poorly correlated
-0.45%
BWAY - PXMBF
22%
Poorly correlated
-0.75%
ISPC - PXMBF
21%
Poorly correlated
+27.42%
SARTF - PXMBF
7%
Poorly correlated
N/A
More

SARTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SARTF has been loosely correlated with SDMHF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if SARTF jumps, then SDMHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SARTF
1D Price
Change %
SARTF100%
N/A
SDMHF - SARTF
39%
Loosely correlated
+0.18%
SOAGY - SARTF
27%
Poorly correlated
+3.02%
EXAS - SARTF
21%
Poorly correlated
+4.67%
RSMDF - SARTF
16%
Poorly correlated
N/A
RYLPF - SARTF
9%
Poorly correlated
N/A
More